Skip to content

Clinical trials

Phase 3 Dyslipidemias trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Phase: Phase 3 Country / region: Mexico Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20066
20071
20081
20091
20122
20131
20171
20181
20211
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda9
Novartis Pharmaceuticals2
89bio, Inc.1
Abbott1
Amarin Pharma Inc.1
Amgen1
Hoffmann-La Roche1
Kowa Research Institute, Inc.1
Laboratorios Grossman, S.A.1
Laboratorios Silanes S.A. de C.V.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias20
Diabetes Mellitus, Type 29
Diabetes Mellitus8
Glucose Metabolism Disorders8
Hypercholesterolemia4
Hyperlipidemias4
Hypertriglyceridemia3
Cardiovascular Diseases2
Diabetes Mellitus, Lipoatrophic2
Atherosclerosis1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.